Anastrozole 1mg research capsules are used in controlled laboratory studies investigating aromatase inhibition, endocrine signaling, estrogen biosynthesis pathways and side effects. Researchers studying anastrozole for men often focus on its potential role in managing estrogen levels in experimental models. Clinical literature also reports documented side effects, making safety data an important consideration during study design. Available in 30, 60 & 100 units, precisely measured for consistency in research outcomes. For laboratory research purposes only — not for human consumption.
Product Details:
• Compound: Anastrozole
• Form: Oral capsules
• Dosage per capsule: 1mg
• Counts available: 30, 60, 90 capsules
• Purity: >99% (HPLC Verified)
• Storage: Store in a cool, dry place away from light
Intended Use:
This compound is intended for laboratory research use only. It is not intended for human consumption, medical, or diagnostic purposes.
Related Research Studies:
- Randomised trial comparing anastrozole vs megestrol acetate in advanced breast cancer (PubMed). Early randomized study evaluating efficacy, tolerability and side effects as a potent non‑steroidal aromatase inhibitor.
- Phase III trial comparing anastrozole doses and megestrol acetate (PubMed). Clinical evaluation of 1 mg vs 10 mg in postmenopausal women with advanced breast carcinoma.
Findings:
Clinical literature characterizes anastrozole as a selective aromatase inhibitor with dose‑response data in endocrine studies.
Related Products:
